Heart Attack

Investigational drug reduces heart damage during angioplasty

A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.

Cardiology created Mar 12, 2013 | popularity not rated yet | comments 1

Drug may improve outcomes after heart attack

The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's ...

Cardiology created Mar 12, 2013 | popularity not rated yet | comments 0

Research reveals high levels of salt in UK restaurant meals

Meals at high street and celebrity chef chain restaurants have been shown to contain high levels of salt which would warrant a red traffic light label in a supermarket, according to research published today ...

Health created Mar 12, 2013 | popularity not rated yet | comments 0

US probes Sanofi over blockbuster drug Plavix (Update 2)

The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.

Medications created Mar 11, 2013 | popularity not rated yet | comments 0

French health estimates delve into Pill risk

A French drug watchdog on Tuesday released estimates for blood clots linked to birth control pills in the wake of fears that so-called third- and fourth-generation oral contraceptives boost a small risk of dangerous thrombosis.

Medications created Mar 26, 2013 | popularity not rated yet | comments 0

Digoxin reduces hospital admissions in older patients with chronic heart failure

Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented today ...

Cardiology created Mar 12, 2013 | popularity not rated yet | comments 0

Heart failure doesn't discriminate

Lifetime risk for heart failure is similar for blacks and whites and higher than expected for both groups—ranging from 20 to 45 percent—according to a new Northwestern Medicine study.

Cardiology created Apr 02, 2013 | popularity not rated yet | comments 0

Study examines hospital readmission and mortality rates for Medicare patients

In a study that included data on nearly 3 million hospital admissions for Medicare beneficiaries with heart attack, pneumonia or heart failure, researchers failed to find evidence that a hospital's performance on the measure ...

Health created Feb 12, 2013 | popularity not rated yet | comments 0

Nearly half of veterans found with blast concussions might have hormone deficiencies

Up to 20 percent of veterans returning from Afghanistan and Iraq have experienced at least one blast concussion. New research suggests that nearly half these veterans may have a problem so under-recognized that even military ...

Diseases, Conditions, Syndromes created Apr 22, 2013 | popularity not rated yet | comments 0

Women live longer, but have a lower quality of life

To mark International Women's Day on 8th March 2013, the Institute of Gender Medicine at the MedUni Vienna has presented an alarming result obtained from gender-specific research. According to recent studies, ...

Health created Mar 11, 2013 | popularity not rated yet | comments 0

PTSD linked to insulin resistance and metabolic syndrome, early markers of heart disease

Patients diagnosed with post-traumatic stress disorder (PTSD) have a significantly higher risk of developing insulin resistance and metabolic syndrome, placing them at greater risk for heart disease and diabetes, according ...

Cardiology created Mar 07, 2013 | popularity not rated yet | comments 0

American College of Physicians unveils tools to improve acute coronary syndrome care

The American College of Physicians (ACP) today unveiled two evidence-based interventions and two videos to improve the health outcomes of patients in the first year following an initial acute coronary syndrome (ACS) event ...

Cardiology created Apr 12, 2013 | popularity not rated yet | comments 0

Shock teams and ECMO save lives in massive STEMI

The use of extracorporeal membrane oxygenation (ECMO), accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. These study findings are being presented March 9 at the ...

Cardiology created Mar 11, 2013 | popularity not rated yet | comments 0

Cangrelor superior to clopidogrel in CHAMPION PHOENIX trial

The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX ...

Cardiology created Mar 11, 2013 | popularity not rated yet | comments 1

Men and women get sick in different ways

At the dawn of third millennium medical researchers still know very little about gender-specific differences in illness, particularly when it comes to disease symptoms, influencing social and psychological factors, and the ...

Cardiology created Mar 22, 2013 | popularity 4 / 5 (1) | comments 1


Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack, results from the interruption of blood supply to a part of the heart, causing heart cells to die. This is most commonly due to occlusion (blockage) of a coronary artery following the rupture of a vulnerable atherosclerotic plaque, which is an unstable collection of lipids (cholesterol and fatty acids) and white blood cells (especially macrophages) in the wall of an artery. The resulting ischemia (restriction in blood supply) and ensuing oxygen shortage, if left untreated for a sufficient period of time, can cause damage or death (infarction) of heart muscle tissue (myocardium).

Classical symptoms of acute myocardial infarction include sudden chest pain (typically radiating to the left arm or left side of the neck), shortness of breath, nausea, vomiting, palpitations, sweating, and anxiety (often described as a sense of impending doom). Women may experience fewer typical symptoms than men, most commonly shortness of breath, weakness, a feeling of indigestion, and fatigue. Approximately one-quarter of all myocardial infarctions are "silent", that is without chest pain or other symptoms.

Among the diagnostic tests available to detect heart muscle damage are an electrocardiogram (ECG), echocardiography, cardiac MRI and various blood tests. The most often used blood markers are the creatine kinase-MB (CK-MB) fraction and the troponin levels. Immediate treatment for suspected acute myocardial infarction includes oxygen, aspirin, and sublingual nitroglycerin.

Most cases of STEMI (ST elevation MI) are treated with thrombolysis or percutaneous coronary intervention (PCI). NSTEMI (non-ST elevation MI) should be managed with medication, although PCI is often performed during hospital admission. In people who have multiple blockages and who are relatively stable, or in a few emergency cases, bypass surgery may be an option, especially in diabetics.

Heart attacks are the leading cause of death for both men and women worldwide. Important risk factors are previous cardiovascular disease, older age, tobacco smoking, high blood levels of certain lipids (triglycerides, low-density lipoprotein) and low levels of high density lipoprotein (HDL), diabetes, high blood pressure, obesity, chronic kidney disease, heart failure, excessive alcohol consumption, the abuse of certain drugs (such as cocaine and methamphetamine), and chronic high stress levels.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Vicious cycle: Obesity sustained by changes in brain biochemistry

With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...

White matter imaging provides insight into human and chimpanzee aging

(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.